MedservRegis p.l.c. Statistics

Total Valuation

MSE:MDS has a market cap or net worth of EUR 40.66 million. The enterprise value is 94.47 million.

Market Cap	40.66M
Enterprise Value	94.47M

Important Dates

The last earnings date was Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	May 12, 2025

Share Statistics

MSE:MDS has 101.64 million shares outstanding.

Current Share Class	101.64M
Shares Outstanding	101.64M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	57.95%
Owned by Institutions (%)	n/a
Float	20.38M

Valuation Ratios

The trailing PE ratio is 21.79.

PE Ratio	21.79
Forward PE	n/a
PS Ratio	0.58
PB Ratio	0.71
P/TBV Ratio	0.97
P/FCF Ratio	3.25
P/OCF Ratio	2.34
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.92, with an EV/FCF ratio of 7.55.

EV / Earnings	50.62
EV / Sales	1.35
EV / EBITDA	5.92
EV / EBIT	14.79
EV / FCF	7.55

Financial Position

The company has a current ratio of 2.30, with a Debt / Equity ratio of 1.24.

Current Ratio	2.30
Quick Ratio	2.11
Debt / Equity	1.24
Debt / EBITDA	4.48
Debt / FCF	5.72
Interest Coverage	1.52

Financial Efficiency

Return on equity (ROE) is 3.62% and return on invested capital (ROIC) is 3.09%.

Return on Equity (ROE)	3.62%
Return on Assets (ROA)	2.74%
Return on Invested Capital (ROIC)	3.09%
Return on Capital Employed (ROCE)	5.03%
Revenue Per Employee	81,121
Profits Per Employee	2,162
Employee Count	866
Asset Turnover	0.48
Inventory Turnover	79.59

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.33% in the last 52 weeks. The beta is -0.61, so MSE:MDS's price volatility has been lower than the market average.

Beta (5Y)	-0.61
52-Week Price Change	-33.33%
50-Day Moving Average	0.54
200-Day Moving Average	n/a
Relative Strength Index (RSI)	39.92
Average Volume (20 Days)	15,432

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MSE:MDS had revenue of EUR 70.01 million and earned 1.87 million in profits. Earnings per share was 0.02.

Revenue	70.01M
Gross Profit	19.66M
Operating Income	6.39M
Pretax Income	3.87M
Net Income	1.87M
EBITDA	11.54M
EBIT	6.39M
Earnings Per Share (EPS)	0.02

Full Income Statement

Balance Sheet

The company has 18.95 million in cash and 71.56 million in debt, giving a net cash position of -52.60 million or -0.52 per share.

Cash & Cash Equivalents	18.95M
Total Debt	71.56M
Net Cash	-52.60M
Net Cash Per Share	-0.52
Equity (Book Value)	57.61M
Book Value Per Share	0.55
Working Capital	24.45M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 17.40 million and capital expenditures -4.88 million, giving a free cash flow of 12.52 million.

Operating Cash Flow	17.40M
Capital Expenditures	-4.88M
Free Cash Flow	12.52M
FCF Per Share	0.12

Full Cash Flow Statement

Margins

Gross margin is 28.08%, with operating and profit margins of 9.12% and 2.67%.

Gross Margin	28.08%
Operating Margin	9.12%
Pretax Margin	5.53%
Profit Margin	2.67%
EBITDA Margin	16.48%
EBIT Margin	9.12%
FCF Margin	17.88%

Dividends & Yields

This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 7.38%.

Dividend Per Share	0.03
Dividend Yield	7.38%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	53.54%
Buyback Yield	n/a
Shareholder Yield	7.38%
Earnings Yield	4.59%
FCF Yield	30.79%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MSE:MDS has an Altman Z-Score of 1.44. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.44
Piotroski F-Score	n/a